Search

Your search keyword '"Visca, D."' showing total 197 results

Search Constraints

Start Over You searched for: Author "Visca, D." Remove constraint Author: "Visca, D."
197 results on '"Visca, D."'

Search Results

1. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease

2. Alpha-1 deficiency in severe asthma patients

3. Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

5. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

6. Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease

7. Clinical standards for the diagnosis and management of asthma in low- and middle-income countries

8. External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019

9. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment

10. Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment

11. A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings

13. A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings.

15. Role of Asthma School in disease management

16. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment

17. Predictors of uptake of ambulatory oxygen on completion of the ambox trial, a study to assess effects of ambulatory oxygen on quality of life in patients with fibrotic interstitial lung disease: S57

18. Tuberculosis and COVID-19 co-infection: description of the global cohort

19. Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment

20. Tuberculosis and COVID-19 co-infection: description of the global cohort

21. Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors’ reply

23. TB and COVID-19 co-infection: rationale and aims of a global study

24. Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

25. Severe asthma: One disease and multiple definitions

26. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

31. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC)

32. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

33. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.

36. Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis

38. Classifying new anti-tuberculosis drugs: rationale and future perspectives

39. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

40. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

41. Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns

42. S69 Verification of genetic associations with scleroderma associated interstitial lung disease

43. S86 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis

46. DEVELOPING RADIATION RESISTANT THERMAL NEUTRON DETECTORS FOR THE E_LIBANS PROJECT: PRELIMINARY RESULTS

47. S57 Predictors of uptake of ambulatory oxygen on completion of the ambox trial, a study to assess effects of ambulatory oxygen on quality of life in patients with fibrotic interstitial lung disease

48. P32 Role of non acid and proximal reflux in scleroderma-associated interstitial lung disease

49. Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases

Catalog

Books, media, physical & digital resources